Baltimore, MD, United States of America

Kevin Chen


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Kevin Chen

Introduction

Kevin Chen, an inventive mind based in Baltimore, MD, has made significant strides in the realm of medical innovations. With one patent to his name, Chen is dedicated to improving therapies against challenging infections.

Latest Patents

Kevin Chen's notable patent, titled "Yeast-based immunotherapy against Clostridium difficile infection," describes novel antibody-based binding agents derived from human and camelid immunoglobulins. This groundbreaking patent encompasses engineered yeast strains that secrete these binding agents, providing methods for treating and preventing infections. The binding agents specifically recognize and adhere to toxin A and/or toxin B, demonstrating neutralizing activity in select instances. The innovative binding agents include camelid VH peptide monomers, linked groups of VH peptide monomers, VH peptide monomers combined with antibody Fc domains, and those joined to IgG antibodies.

Career Highlights

Kevin Chen is currently associated with the University of Maryland, Baltimore, where he continues to conduct research and contribute to the field of immunotherapy. His work not only reflects a commitment to scientific advancement but also emphasizes the practical implications of his innovations in combating infections.

Collaborations

While working at the University of Maryland, Baltimore, Kevin collaborates with respected colleagues such as Hanping Feng and James Eugene Galen. These collaborations enhance the research environment, fostering an atmosphere of shared knowledge and innovation aimed at enhancing healthcare solutions.

Conclusion

Kevin Chen's contributions to the field of immunotherapy illustrate the power of innovation in addressing public health challenges. Through his patent and collaborative efforts, he demonstrates how inventive solutions can pave the way for effective treatment options against resistant infections. The future looks promising, with innovators like Chen leading the charge towards medical breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…